Search company, investor...

Antares Pharma

antarespharma.com

Founded Year

1979

Stage

Acq - P2P | Acquired

Total Raised

$6.2M

Valuation

$0000 

Revenue

$0000 

About Antares Pharma

On May 24th, 2022, Antares Pharma was acquired by Halozyme Therapeutics. Antares Pharma is a specialized pharmaceutical firm primarily dedicated to the development and marketing of pharmaceutical medicines and technology that answer patient requirements in certain therapeutic areas. The company was founded in 1979 and is based in Ewing, NJ.

Headquarters Location

250 Phillips Boulevard Suite 290

Ewing, New Jersey, 08618,

United States

609-359-3020

Missing: Antares Pharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Antares Pharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Antares Pharma Patents

Antares Pharma has filed 1 patent.

The 3 most popular patent topics include:

  • Drug delivery devices
  • Medical equipment
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/16/2019

11/15/2022

Autoimmune diseases, Rheumatology, Inflammations, Systemic connective tissue disorders, Monoclonal antibodies

Grant

Application Date

12/16/2019

Grant Date

11/15/2022

Title

Related Topics

Autoimmune diseases, Rheumatology, Inflammations, Systemic connective tissue disorders, Monoclonal antibodies

Status

Grant

Latest Antares Pharma News

Needle-Free Drug Injection Systems Market is Projected to Reach US$ 59.72 Billion in 2028

Nov 25, 2022

The report has a very high utility for the key decision-makers and strategists in terms of accurate market insights, future growth opportunities, and key success factors. Most importantly, the report analyses the possible impact of COVID-19 on the market dynamics which offers cushioning against the uncertain business environment and helps in streamlining the resources and investment decisions in a fruitful manner. According to the report, the needle-free drug injection systems market is driven by a host of factors, some of which are noted below: The increasing prevalence of chronic diseases due to changing lifestyles and unhealthy diets. Expanding geriatric populace is another factor likely to drive the growth of needle-free drug injection systems at a significant rate during the review period. Surging demand for advanced drug delivery systems. The report also includes growth rate estimates based upon the intensity of drivers and constraints and provides the users with several graphical illustrations of the key insights. Needle-Free Drug Injection Systems Market Segmentation: Stratview Research has segmented the market in the following ways which fulfill the market data needs of multiple stakeholders across the industry value chain. By Type (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors). By Application (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical, and Biotechnology companies, Others). By Region (North America, Europe, Asia-Pacific, and the Rest of the World). Needle-Free Drug Injection Systems Market Insights Market Trends by Application Type The market has been bifurcated into hospitals and clinics, home care settings, research laboratories, pharmaceutical, and biotechnology companies, and others. Under these, the hospitals & clinics segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established infrastructure and skilled healthcare professionals. Which region offers the best opportunity and growth? North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the high demand for advanced drug delivery systems coupled with the presence of key market players such as Antares Pharma, Inc. (US) and Endo International plc (US). The market growth in the Asia-Pacific region is expected to be driven by increasing spending on healthcare. COVID-19 Impact on the Needle-Free Drug Injection Systems Market COVID-19 has put an instant halt to many industries across the globe. Lockdown norms in several countries have swiftly affected the global economy by affecting the supply chain, production, and demand in the market. Both direct, as well as indirect impacts of the pandemic, have been incorporated in this report. To know more about the covid-19 impact, get a free sample report, here: Who are the Top Market Players? After a thorough analysis of the market, the experts have listed a few key players and discussed company profiles of the below-given players - Antares Pharma, Inc. (US), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), Valeritas, Inc. (US), In-depth analysis of the needle-free drug injection systems market. Detailed market segmentation. About us – Stratview Research is a global market research firm that offers reliable market reports, market entry strategies, strategic growth consulting, and more. The market experts compile high-quality market information to help users obtain granular level clarity on current business trends and expected future developments. Stratview Research also offers customisation of the reports. Reach out to the analysts to customize the given report according to your priority/requirement. Stratview Research has also launched 'Composights', an online portal that offers free thought leadership reports, whitepapers, market report synopsis, and much more for Composites and allied industries, worth US$ 20,000 every year. Click here to sign up (No costs involved):

Antares Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Antares Pharma Rank

Antares Pharma Frequently Asked Questions (FAQ)

  • When was Antares Pharma founded?

    Antares Pharma was founded in 1979.

  • Where is Antares Pharma's headquarters?

    Antares Pharma's headquarters is located at 250 Phillips Boulevard, Ewing.

  • What is Antares Pharma's latest funding round?

    Antares Pharma's latest funding round is Acq - P2P.

  • How much did Antares Pharma raise?

    Antares Pharma raised a total of $6.2M.

  • Who are the investors of Antares Pharma?

    Investors of Antares Pharma include Halozyme Therapeutics, HSBC, MMV Financial, Hudson Bay Capital Management, Iroquois Capital Group and 47 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.